845,900 Shares in R1 RCM Inc. (NASDAQ:RCM) Acquired by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. bought a new stake in R1 RCM Inc. (NASDAQ:RCM - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 845,900 shares of the healthcare provider's stock, valued at approximately $11,986,000. Tokio Marine Asset Management Co. Ltd. owned approximately 0.20% of R1 RCM as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. GAMMA Investing LLC raised its position in shares of R1 RCM by 41.3% during the third quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider's stock worth $37,000 after acquiring an additional 759 shares during the last quarter. Arizona State Retirement System increased its position in shares of R1 RCM by 2.1% during the second quarter. Arizona State Retirement System now owns 47,063 shares of the healthcare provider's stock worth $591,000 after buying an additional 969 shares during the period. QRG Capital Management Inc. lifted its holdings in R1 RCM by 10.6% in the second quarter. QRG Capital Management Inc. now owns 11,307 shares of the healthcare provider's stock valued at $142,000 after buying an additional 1,080 shares during the period. Advisors Asset Management Inc. bought a new stake in R1 RCM during the first quarter valued at $27,000. Finally, Texas Permanent School Fund Corp grew its holdings in R1 RCM by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 172,179 shares of the healthcare provider's stock worth $2,218,000 after acquiring an additional 2,135 shares during the period. Institutional investors and hedge funds own 61.10% of the company's stock.

R1 RCM Price Performance

RCM stock remained flat at $14.30 during midday trading on Thursday. 11,355,268 shares of the company's stock traded hands, compared to its average volume of 3,469,054. The firm has a 50-day moving average of $14.20 and a 200-day moving average of $13.37. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 0.76. R1 RCM Inc. has a 52 week low of $8.87 and a 52 week high of $15.12. The company has a market cap of $6.04 billion, a price-to-earnings ratio of -95.33 and a beta of 0.84.

R1 RCM (NASDAQ:RCM - Get Free Report) last announced its earnings results on Tuesday, November 5th. The healthcare provider reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.04). R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The business had revenue of $656.80 million during the quarter, compared to analyst estimates of $640.93 million. The firm's revenue for the quarter was up 14.7% on a year-over-year basis. On average, sell-side analysts expect that R1 RCM Inc. will post -0.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Truist Financial decreased their price target on R1 RCM from $16.00 to $14.30 and set a "hold" rating for the company in a report on Thursday, August 8th. Leerink Partnrs downgraded shares of R1 RCM from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 1st. Stephens downgraded R1 RCM from an "overweight" rating to an "equal weight" rating in a report on Thursday, August 1st. Morgan Stanley downgraded R1 RCM from an "overweight" rating to an "equal weight" rating in a report on Thursday, August 8th. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $14.30 price objective on shares of R1 RCM in a research report on Friday, October 4th. Thirteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, R1 RCM presently has a consensus rating of "Hold" and an average target price of $15.41.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.